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Pulmonary metastatic melanoma
To the Editor:
I read with interest the article by Rebecca
and colleagues.1 I want to commend the
authors for their great effort to produce this
important article, but I have some com-
ments about it.
The type of extrathoracic metastasis can
affect the prognosis, but you did not men-
tion which type of extrathoracic metastasis
was present. The number of these extratho-
racic metastasis also was not mentioned. I
think that these extrathoracic metastases,
even with their control, are a contraindica-
tion for further surgical intervention.
The frequency of the site of these pul-
monary metastasis was also not mentioned.
From your results there were 23 bilateral
thoracotomies: were they done at the same
sitting or in sequence? Why did you not
perform median sternotomy for bilateral
management of these metastasis?
I want also to ask about the side of
pulmonary metastasis and its effect for the
prognosis.
From the results, you had mentioned
that the median follow-up of living patients
was 65 months (0.1–524 months).1 From
that result I can suggest that the least time
for follow-up was 0.1 month, which equals
only 3 days. That is too little for follow-up.
Also, the maximum follow-up was 524
months, which equals 43.6 years. That ex-
ceeds the proposed time of the study (from
January 1, 1970, to June 1, 2004, which is
only about 34.5 years).
My last comment concerns the last
word of your article: It reads Figure E3; I
think that you meant Figure 1.
Mohamed Fouad Ismail, MD
Cardiothoracic Surgery Department
Mansoura University Hospitals
Mansoura, Egypt
[Response declined]
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Superior vena cava resection
without blood flow interruption
To the Editor:
We agree with Leo and associates1 that
clamping of the superior vena cava (SVC)
can cause severe hemodynamic changes
with possible serious clinical conse-
quences, particularly when the SVC blood
flow was not already gradually reduced by
venous wall pathology, usually neoplastic
infiltration. For this reason, at the begin-
ning of our clinical experience with SVC
resections, we successfully used a tempo-
rary intraluminal shunt.2
However, after a few cases, we shifted
to the much more simple and accurate tech-
nique of performing, as the first procedure
after sternotomy (or thoracotomy), ringed
polytetrafluoroethylene graft (12–18 mm)
interposition between the amputated right
atrial appendage tip and the left (occasion-
ally right on thoracotomy cases) brachioce-
phalic trunk (Figure 1). This procedure
does not interrupt blood flow through the
SVC (Figure 1, A), and after the blood flow
through this conduit is established, SVC
clamping (Figure 1, B) and removal (Fig-
Figure 1. In all phases of the procedure, upper body district venous discharge is maintained through one of the
brachiocephalic trunks.
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ure 1, C) can be carried out with neither
clamping time limits nor significant hemo-
dynamic changes.
We prefer not to reestablish the pros-
thetic continuity of the right brachioce-
phalic trunk with the “atrial” SVC stump
because the upper body district venous
blood sharing between 2 prosthetic con-
duits might enhance reduced blood velocity
in one of them and its possible thrombosis
and infection (3/6 cases of double pros-
thetic conduits SVC reconstruction in our
series).
Obviously, in those infrequent cases in
which the SVC can still be patch repaired
but the lesion is too extended to allow
tangential clamping, the polytetrafluoro-
ethylene graft is kept only temporarily3 and
then removed after SVC reconstruction is
completed.
Moreover, even in those cases in which
it seems appropriate to site the distal anas-
tomosis on the SVC, the clamping time can
be reduced to half if the conduit is first
anastomosed to the right atrial appendage
instead of to the proximal SVC stump.
Claudio Rossella, MDa
Stefano Nazari, MDa,b
Consultant, Villa Maria Cecilia Hospital
Cotignola, RA, Italya
Foundation A. Carrel
Pavia, Italyb
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Reply to the Editor:
We thank Drs Rossella and Nazari for their
technical comments on the possibility of
reconstructing the superior vena cava
(SVC) without the need of crossclamping
by connecting one brachiocephalic vein
(BCV) to the right atrial appendage. It rep-
resents an interesting alternative by avoid-
ing temporary SVC occlusion, but we still
prefer SVC crossclamping for 3 reasons.
First, in our experience, SVC recon-
struction with the BCV stump is at higher
risk of thrombosis. We recently reported
our experience with 70 cases of SVC re-
section from 1998 through 2004.1 Of the
25 complete prosthetic replacements, 6
thromboses were recorded, and 4 of them
(66%) were in patients with BCV recon-
struction. Possible explanations are the
length of the prosthesis, the limited diam-
eter of the BCV, and the discrepancy be-
tween SVC and BCV calibers. At present,
our indication for BCV reconstruction is
limited to situations in which an alternative
is not feasible.
Second, hemodynamic instability oc-
curring at SVC crossclamping is a limited
problem as long as anesthetists are aware
of methods to overcome it.2 It is a frequent
event (30%) that can be managed in almost
all cases with aggressive resuscitation ma-
neuvers. Intraoperative hypotension by it-
self should not stop the operation unless
corrective maneuvers are unsuccessful (5%
of cases). On the other hand, in our expe-
rience right atrial appendage clamping can
also cause intraoperative patient instability
through the occurrence of supraventricular
arrhythmias.
Third, our preference for an SVC pros-
thesis is the use of bovine pericardium,3
which is a reliable material, even in the
context of pulmonary artery reconstruc-
tion.4 In case of sternotomy or a transma-
nubrial approach, such a prosthesis on the
left BCV might become occluded by ma-
nubrial compression at sternal closure.
When a left BCV reconstruction is re-
quired, we prefer a ringed polytetrafluoro-
ethylene prosthesis.
Francesco Leo, MD, PhDa
Lorenzo Spaggiari, MD, PhDa,b
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